Chlamydia pneumoniae

Tiny germs can make people sick.

These germs live inside our cells. They must go inside a cell to grow. They travel in small drops in the air.

These germs can cause a bad cough. They can also make it hard to breathe. Some animals like frogs can get them too. It is a common cause of lung sickness. Scientists study these germs to help us stay well.

Chlamydia pneumoniae is a tiny germ. We call these germs bacteria. They are very small.

This germ must live inside a living cell to grow. Because it needs a host cell, scientists call it an obligate intracellular pathogen.

The germ has a special way of life. It starts as an elementary body. This part is not active, but it can survive outside a host. It travels in small drops in the air. When a person breathes these drops, the germ enters the lungs.

Once inside, the germ changes. It becomes a reticulate body. This new part can make more germs. It uses power from the host cell to do this. Soon, the germs turn back into elementary bodies. They leave the cell to find new ones.

This germ can cause many sicknesses. It is a common cause of pneumonia. It can also cause asthma or bronchitis. Some animals get it too. This includes frogs, turtles, and even koalas. Scientists are still looking for a vaccine to stop it.

Chlamydia pneumoniae is a tiny bacterium that can cause many sicknesses. It is an obligate intracellular pathogen. This means it must live inside a living cell to reproduce. This germ is a major cause of pneumonia around the world. People often catch it in their local communities. It can also cause bronchitis or pharyngitis. Some studies even link it to heart issues like coronary artery disease.

The germ has a very special way of working. It starts as an elementary body, or EB. The EB is not active, but it can survive outside a host. It travels through the air in small droplets. When a person breathes these in, the EB enters the lung cells. The cell takes the EB inside a small pouch. Once inside, the EB changes into a reticulate body, or RB.

This new RB stage is when the germ grows. The RB uses the host cell's energy to make more bacteria. After it replicates, the RBs turn back into elementary bodies. These new EBs are released to find new cells. Often, this process causes the host cell to die. The new EBs can then infect other cells or new people. This cycle helps the bacterium spread and survive.

Scientists have studied this bacterium for a long time. The first known case was in Taiwan in 1950. It was a case of eye redness called conjunctivitis. Before 1950, there were no known cases in human history. It was once even thought to be a virus. Later, it was called the Taiwan acute respiratory agent, or TWAR. This name came from two original samples called TW-183 and AR-39. The full genome sequence was finally published in 1999.

This bacterium affects many different living things. It can infect koalas, iguanas, and even frogs. It can also make turtles and emerald tree boas sick. In humans, it is a common cause of atypical pneumonia. This type of pneumonia is different from other kinds. It is hard to see with a standard gram stain. Doctors often use special antibiotics like azithromycin to treat it. There is still no vaccine to prevent these infections.

Chlamydia pneumoniae is a species of Chlamydia bacterium. It is classified as an obligate intracellular pathogen. This means it must live inside a host cell to reproduce. It is a small, gram-negative bacterium measuring between 0.2 and 1 micrometer. This organism is a major cause of pneumonia in humans around the world. It can also cause pharyngitis, bronchitis, and coronary artery disease.

The life cycle of this bacterium involves complex transformations. It exists in two distinct stages to survive and spread. The first stage is the elementary body, or EB. The EB is not biologically active. However, it is resistant to environmental stresses. This allows the EB to survive outside a host for a limited time. EBs travel from person to person through small droplets in the air.

Once an EB enters the lungs, the infection process begins. The lung cells take up the EB through a process called phagocytosis. This occurs when the cell pulls the bacterium into a pouch called an endosome. Normally, a cell would destroy such material using lysosomes. However, the EB avoids destruction. Instead, it transforms into a reticulate body, or RB. The RB stage is when the bacterium begins to replicate.

Replication requires the bacterium to use the host cell's own metabolism. The RBs multiply within the endosome using the cell's energy. After replication is complete, the RBs convert back into elementary bodies. These new EBs are then released back into the lung. This release often causes the death of the host cell. The new EBs are then ready to infect new cells or new hosts.

Scientists have a long history of studying this pathogen. The first known human case occurred in 1950 in Taiwan. This case involved conjunctivitis, which is eye redness. Before 1950, there were no known cases in human history. The bacterium was once known as the Taiwan acute respiratory agent, or TWAR. This name came from two original isolates named TW-183 and AR-39. Researchers eventually published the full genome sequence in 1999.

This bacterium is known for causing atypical pneumonia. This term is used because the infection is different from common causes like Streptococcus pneumoniae. It does not show up well during a standard gram stain. In 1991, researchers linked the infection to wheezing and asthma. Studies of pediatric patients showed that over 50 percent had evidence of the bacterium. Some research suggests that C. pneumoniae may be associated with an increased risk of lung cancer.

Beyond respiratory issues, the bacterium is linked to other serious conditions. It is considered a significant risk factor for atherosclerosis. This is a condition involving the development of atherosclerotic plaques in the arteries. It has also been found in the cerebrospinal fluid of patients with multiple sclerosis. Some studies even suggest an association with schizophrenia. It has also been found as a possible cause of chronic fatigue syndrome.

Treatment for C. pneumoniae requires specific types of antibiotics. Macrolides, such as azithromycin and clarithromycin, are often used. Tetracyclines like doxycycline are also effective first-line treatments. However, the bacterium shows resistance to penicillin, ampicillin, and sulfa drugs. Symptoms can sometimes reappear after short courses of medicine. Therefore, intensive long-term treatment is often recommended after confirming a persistent infection. Currently, there is no vaccine available to prevent these infections.